In a dynamic interview with Bronwyn Nielsen, David Shapiro forecasts a potential strengthening of the Rand, anticipating significant movements below 17.50. Emphasizing both local initiatives and global economic trends, Shapiro discusses promising sectors like weight loss pharmaceuticals, highlighting Novo Nordisk and Eli Lilly as key players. His insights into the bond market's resilience and the transformative potential of medical innovations underscore optimism amidst evolving market conditions, making this dialogue essential for investors navigating today's economic landscape."

Video production by Asime Nyide

Sign up for your early morning brew of the BizNews Insider to keep you up to speed with the content that matters. The newsletter will land in your inbox at 5:30am weekdays. Register here.

Join this channel to get access to perks:
   / @biznewstv